Loading...
Loading...
CDXS| Name | Value |
|---|---|
| Revenues | 30.4M |
| Cost of Revenue | 8.5M |
| Gross Profit | 21.9M |
| Operating Expense | 32.0M |
| Operating I/L | -10.1M |
| Other Income/Expense | -2.4M |
| Interest Income | 0.8M |
| Pretax | -12.5M |
| Income Tax Expense | 0.2M |
| Net Income/Loss | -12.6M |
Codexis, Inc. specializes in discovering, developing, and selling enzymes and other proteins for various applications. The company offers biocatalyst products, intermediate chemicals, and biocatalyst panels and kits for chemistry screening. Additionally, it provides biocatalyst screening and protein engineering services, along with the CodeEvolver protein engineering technology platform. Codexis generates revenue by selling its products and services to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe.
